Jyllinge, Denmark

Rene Holm

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 4.2

ph-index = 5

Forward Citations = 60(Granted Patents)


Company Filing History:


Years Active: 2014-2022

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Rene Holm

Introduction

Rene Holm is a notable inventor based in Jyllinge, Denmark. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of cognitive impairment. With a total of 9 patents to his name, Holm's work has garnered attention for its potential impact on mental health therapies.

Latest Patents

Among his latest patents is the compound 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine. This compound exhibits combined serotonin reuptake, 5-HT3, and 5-HT1A activity, making it a promising candidate for the treatment of cognitive impairment, especially in patients suffering from depression. Another significant patent is for vortioxetine pyroglutamate, which includes the salt and pharmaceutical compositions comprising this salt. These innovations highlight Holm's commitment to advancing therapeutic options for cognitive health.

Career Highlights

Rene Holm is currently associated with H. Lundbeck A/S, a leading pharmaceutical company known for its focus on brain diseases. His work at Lundbeck has allowed him to explore and develop new treatments that address critical mental health issues. Holm's research is characterized by a strong emphasis on the biochemical mechanisms underlying cognitive function and impairment.

Collaborations

Holm has collaborated with several talented individuals in his field, including Heidi Lopez De Diego and Andre Faldt. These collaborations have fostered a productive environment for innovation and have contributed to the successful development of his patents.

Conclusion

Rene Holm's contributions to the field of pharmaceuticals, particularly in cognitive impairment treatments, underscore his role as a significant inventor. His innovative patents and collaborations reflect a dedication to improving mental health therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…